Mary M. Mccormack
London, ENG NW12BU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial.
Journal: Obstetrical & gynecological survey
Published: October 30, 2025
INTERLACE: not a new standard for cervical cancer chemoradiation - Authors' reply.
Journal: Lancet (London, England)
Published: March 28, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: February 26, 2025
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
Journal: Lancet (London, England)
Published: October 17, 2024
INTERLACE in practice.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 09, 2024
Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow Interviews.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 24, 2024
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.
Journal: Cancers
Published: July 16, 2024
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 10, 2024
Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: May 06, 2024
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population☆.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 12, 2024
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC).
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 19, 2024
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 26, 2023
Last Updated: 09/26/2026